Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Fumero

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Antimicrobial Chemotherapy|October 8, 2013
Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C)Beatriz Hernández-Novoa, Ana Moreno, María J Pérez-Elías, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruptionEric Florence, Felipe García, Montserrat Plana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 6, 2007
HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infectionMarta Garrido, Anna Mozos, Antonio Martínez, et al.
Dermatology Practical & Conceptual|August 9, 2023
Smart e-Skin Cancer Care in Europe During and after the Covid-19 Pandemic: a Multidisciplinary Expert ConsensusJosep Malvehy, Brigitte Dreno, Enric Barba, et al.
Immunotherapy|July 20, 2010
Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patientsAlba Ruiz, Meritxell Nomdedeu, Marisa Ortega, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell countFelipe García, Elisa de Lazzari, Montserrat Plana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot studyFelipe García, Montserrat Plana, Mireia Arnedo, et al.
Antiviral Therapy|June 26, 2014
Impact of prior virological failure and nucleos(t)ide genotypic resistance mutations on the efficacy of switching from ritonavir-boosted protease inhibitors to raltegravirJosé L Blanco, Ana Gonzalez-Cordón, Josep M Llibre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2004
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistenceLlúcia Alòs, Pilar Navarrete, Vanesa Morente, et al.
Antiviral Therapy|February 6, 2004
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapyPilar Navarrete, Vanessa Morente, Felipe García, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Antimicrobial Chemotherapy|October 8, 2013
Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C)Beatriz Hernández-Novoa, Ana Moreno, María J Pérez-Elías, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruptionEric Florence, Felipe García, Montserrat Plana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 6, 2007
HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infectionMarta Garrido, Anna Mozos, Antonio Martínez, et al.
Dermatology Practical & Conceptual|August 9, 2023
Smart e-Skin Cancer Care in Europe During and after the Covid-19 Pandemic: a Multidisciplinary Expert ConsensusJosep Malvehy, Brigitte Dreno, Enric Barba, et al.
Immunotherapy|July 20, 2010
Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patientsAlba Ruiz, Meritxell Nomdedeu, Marisa Ortega, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell countFelipe García, Elisa de Lazzari, Montserrat Plana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot studyFelipe García, Montserrat Plana, Mireia Arnedo, et al.
Antiviral Therapy|June 26, 2014
Impact of prior virological failure and nucleos(t)ide genotypic resistance mutations on the efficacy of switching from ritonavir-boosted protease inhibitors to raltegravirJosé L Blanco, Ana Gonzalez-Cordón, Josep M Llibre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2004
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistenceLlúcia Alòs, Pilar Navarrete, Vanesa Morente, et al.
Antiviral Therapy|February 6, 2004
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapyPilar Navarrete, Vanessa Morente, Felipe García, et al.
Pageof 3